These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7729044)

  • 1. Bone alkaline phosphatase and height velocity in short normal children undergoing growth-promoting treatments: longitudinal study.
    Crofton PM; Stirling HF; Kelnar CJ
    Clin Chem; 1995 May; 41(5):672-8. PubMed ID: 7729044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM; Stirling HF; Schönau E; Kelnar CJ
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
    Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between alkaline phosphatase and bone alkaline phosphatase activity and the growth hormone/insulin-like growth factor-1 axis and vitamin D status in children with growth hormone deficiency.
    Witkowska-Sędek E; Stelmaszczyk-Emmel A; Majcher A; Demkow U; Pyrżak B
    Acta Biochim Pol; 2018; 65(2):269-275. PubMed ID: 29649340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting and monitoring of growth in children with short stature during the first year of growth hormone treatment.
    Mortensen HB; Main K; Michaelsen KF; Kastrup KW; Jłrgensen JT; Skakkebaek NE
    Acta Paediatr Scand; 1991 Dec; 80(12):1150-7. PubMed ID: 1785287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate, and normal growth hormone response to secretagogues. (Dutch Growth Hormone Working Group).
    Wit JM; Fokker MH; de Muinck Keizer-Schrama SM; Oostdijk W; Gons M; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ
    J Pediatr; 1989 Nov; 115(5 Pt 1):720-5. PubMed ID: 2809902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
    Ono T; Kanzaki S; Seino Y; Baylink DJ; Mohan S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of growth hormone treatment on serum bone alkaline phosphatase in growth hormone deficient children.
    Korpal-Szczyrska M; Balcerska A
    Pediatr Endocrinol Diabetes Metab; 2008; 14(4):211-4. PubMed ID: 19239787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone on short normal children.
    Hindmarsh PC; Brook CG
    Br Med J (Clin Res Ed); 1987 Sep; 295(6598):573-7. PubMed ID: 3117236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
    Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
    J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Wühl E; Haffner D; Tönshoff B; Mehls O
    Kidney Int Suppl; 1993 Oct; 43():S76-82. PubMed ID: 8246375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
    Crofton PM; Ahmed SF; Wade JC; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
    Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in leg length and height during treatment with somatotropin.
    Wales JK; Milner RD
    Arch Dis Child; 1989 Dec; 64(12):1708-12. PubMed ID: 2696434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency.
    Lesage C; Walker J; Landier F; Chatelain P; Chaussain JL; Bougnères PF
    J Pediatr; 1991 Jul; 119(1 Pt 1):29-34. PubMed ID: 2066855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of growth-promoting therapies. Comparison among growth hormone, clonidine, and levodopa.
    Volta C; Ghizzoni L; Muto G; Spaggiari R; Virdis R; Bernasconi S
    Am J Dis Child; 1991 Feb; 145(2):168-71. PubMed ID: 1994682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final height after growth hormone therapy in short children: correlation with siblings' height.
    Zadik Z; Zung A
    Horm Res; 1997; 48(6):274-7. PubMed ID: 9402245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.